According to GlobalData’s medical device pipeline database, 40 ICP Monitoring Devices devices are in various stages of development globally. GlobalData’s report ICP Monitoring Devices provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, 20 are in active development, while the remaining 22 are in an inactive stage of development. There are 12 products in the early stages of development, and the remaining eight are in the late stages of development.

ICP monitoring devices are medical devices used to measure intracranial pressure (ICP) in patients with neurological conditions that can cause increased pressure in the brain. These neurological conditions may include traumatic brain injury, subarachnoid hemorrhage, hydrocephalus, and brain tumors. Monitoring ICP is important because increased pressure in the brain can lead to brain damage and other serious complications. External ventricular drainage (EVD) and micro transducer devices are covered under this segment. One unit refers to One ICP monitoring device.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed ICP Monitoring Devices pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of ICP Monitoring Devices devices. Overall, most of these ICP Monitoring Devices pipeline devices are being developed by private entities.

Key players involved in the active development of ICP Monitoring Devices include Irras, Spiegelberg, Stanford University, Stanford University, HeadSense Medical, Integrated Sensing Systems, Feinstein Institute for Medical Research, Third Eye Diagnostics, University of Illinois and Virginia Commonwealth University.

For a complete picture of the developmental pipeline for ICP Monitoring Devices devices, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.